JAK Inhibitors Remain a Viable Option for Older Adults With IBD

You don’t have permission to access “http://www.medpagetoday.com/meetingcoverage/ccc/114145” on this server. Reference #18.b6e5c417.1739174src64.6f6195srcb https://errors.edgesuite.net/18.b6e5c417.1739174src64.6f6195srcb

You don’t have permission to access “http://www.medpagetoday.com/meetingcoverage/ccc/114145” on this server.

Reference #18.b6e5c417.1739174src64.6f6195srcb

https://errors.edgesuite.net/18.b6e5c417.1739174src64.6f6195srcb

Tama Mischke

See author's posts

JAK Inhibitors Remain a Viable Option for Older Adults With IBD

About Author

Tama Mischke

Novo’s Weight Loss Drugs Removed from FDA Shortage List

‘Active recovery’ after exercise is supposed to improve performance—but does it really work?

Does Taking ‘The Pill’ Reduce Ovarian Cancer Risk?

Novo’s Weight Loss Drugs Removed from FDA Shortage List

‘Active recovery’ after exercise is supposed to improve performance—but does it really work?

The Surprising Source of Next-Gen Antibiotics: Oyster Blood

New GLP-1 Data Reinforce CV Benefit

Tool Predicts Whether One Bruise in Pediatric ED Signals Abuse

New lung scanning method can show treatment effects in real time

Engineering a smile: Stem cell–based conduits restore facial nerve function in animal study

10 FSA/HSA Eligible Fitness Items, Recommended by Our Editors

Engineered T cells could help patients overcome resistance to CAR T cell therapy

The 15 Best Beard Products for Men in 2025, Tested by Grooming Editors

Novo’s Weight Loss Drugs Removed from FDA Shortage List

‘Active recovery’ after exercise is supposed to improve performance—but does it really work?

The Surprising Source of Next-Gen Antibiotics: Oyster Blood

New GLP-1 Data Reinforce CV Benefit

Tool Predicts Whether One Bruise in Pediatric ED Signals Abuse

About PhaMed

Recent News

About Author

More Stories

You may have missed

About PhaMed

Recent News

Categories